Comparing the Effects of Oral Contraceptives Containing Levonorgestrel With Products Containing Antiandrogenic Progestins on Clinical, Hormonal, and Metabolic Parameters and Quality of Life in Women With Polycystic Ovary Syndrome: Crossover Randomized Controlled Trial Protocol

BACKGROUND: Oral contraceptives (OCs) have been used as a first-line option for medical treatment in women with polycystic ovary syndrome (PCOS). Despite theoretical superiority of products containing antiandrogenic progestins compared to OCs containing levonorgestrel (LNG), the clinical advantage o...

Descripción completa

Detalles Bibliográficos
Autores principales: Amiri, Mina, Nahidi, Fatemeh, Khalili, Davood, Bidhendi-Yarandi, Razieh, Ramezani Tehrani, Fahimeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2017
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640820/
https://www.ncbi.nlm.nih.gov/pubmed/28963092
http://dx.doi.org/10.2196/resprot.8631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640820/
https://www.ncbi.nlm.nih.gov/pubmed/28963092
http://dx.doi.org/10.2196/resprot.8631

Ejemplares similares